Vir Biotechnology, Inc. (VIR)
收市後：
| 前收市價 | 9.93 |
| 開市 | 9.94 |
| 買盤 | 9.71 x 300 |
| 賣出價 | 9.77 x 100 |
| 今日波幅 | 9.61 - 10.04 |
| 52 週波幅 | 7.61 - 27.48 |
| 成交量 | |
| 平均成交量 | 988,395 |
| 市值 | 1.324B |
| Beta 值 (5 年，每月) | 0.46 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -4.01 |
| 業績公佈日 | 2024年8月01日 - 2024年8月05日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 32.29 |
ZacksWall Street Analysts Think Vir Biotechnology (VIR) Could Surge 188.65%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 188.7% in Vir Biotechnology (VIR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Insider MonkeyVir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript
Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript May 3, 2024 Vir Biotechnology, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello. Welcome to Vir Biotechnology’s First Quarter 2024 Financial Results and Business Update Call. As a reminder, […]
ZacksVir Biotechnology, Inc. (VIR) Reports Q1 Loss, Tops Revenue Estimates
Vir Biotechnology (VIR) delivered earnings and revenue surprises of 51.52% and 250.82%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
